Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+ CD25+ Foxp3+ regulatory T …
S Iyama, K Murase, T Sato, A Hashimoto… - International journal of …, 2014 - Springer
Narrowband ultraviolet B phototherapy (NB-UVB) is a therapeutic alternative for
haematopoietic stem cell transplantation-related skin graft-versus-host disease (GVHD). The …
haematopoietic stem cell transplantation-related skin graft-versus-host disease (GVHD). The …
Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin
JV Feldstein, J Bolaños-Meade, VL Anders… - Journal of the American …, 2011 - Elsevier
BACKGROUND: Acute graft-versus-host disease (aGvHD) is a common complication of
allogeneic stem cell transplantation. It is usually treated with high doses of corticosteroids …
allogeneic stem cell transplantation. It is usually treated with high doses of corticosteroids …
[HTML][HTML] Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome
M Yüksel, E Baron, M Camouse, BW Cooper… - Biology of Blood and …, 2006 - Elsevier
Whole-body UV-B phototherapy has been used for the treatment of graft-versus-host
disease (GVHD) of the skin and has systemic immunosuppressive and tolerogenic effects …
disease (GVHD) of the skin and has systemic immunosuppressive and tolerogenic effects …
[HTML][HTML] Narrow-band ultraviolet B phototherapy ameliorates acute graft-versus-host disease of the intestine by expansion of regulatory T cells
A Hashimoto, T Sato, S Iyama, M Yoshida, S Ibata… - PloS one, 2016 - journals.plos.org
Narrowband ultraviolet B (NB-UVB) has been widely used in dermatological phototherapy.
As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we …
As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we …
[HTML][HTML] Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease
M Kreutz, S Karrer, P Hoffmann, E Gottfried… - Journal of investigative …, 2012 - Elsevier
Depletion of host Langerhans cells (LCs) prevents cutaneous graft-versus-host disease
(GvHD) in mice. We analyzed whether UVB irradiation is tolerated during the course of …
(GvHD) in mice. We analyzed whether UVB irradiation is tolerated during the course of …
Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease
M Grundmann-Kollmann, H Martin, R Ludwig… - …, 2002 - journals.lww.com
Graft versus host disease (GVHD) is an important problem following allogenic bone marrow
transplantation (BMT). The beneficial effects of photochemotherapy with psoralens plus UVA …
transplantation (BMT). The beneficial effects of photochemotherapy with psoralens plus UVA …
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin
T Wetzig, M Sticherling, JC Simon… - Bone marrow …, 2005 - nature.com
Long-wavelength ultraviolet A (340–400 nm UVA1) phototherapy has been reported to be
effective in atopic dermatitis, localized scleroderma and other T-cell-derived skin diseases …
effective in atopic dermatitis, localized scleroderma and other T-cell-derived skin diseases …
Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease
PC Pinton, F Porta, T Izzi, M Venturini… - …, 2003 - haematologica.org
BACKGROUND AND OBJECTIVES: Standard or investigative immunosuppressive
therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only …
therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only …
Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft‐versus‐host disease in oncohaematological paediatric patients
V Brazzelli, V Grasso, F Muzio, E Moggio… - British Journal of …, 2010 - academic.oup.com
Background Graft‐versus‐host disease (GVHD) represents an important complication
following allogeneic bone marrow transplantation. In recent years, narrowband ultraviolet B …
following allogeneic bone marrow transplantation. In recent years, narrowband ultraviolet B …
Narrowband UV-B phototherapy for steroid-refractory sclerotic chronic cutaneous graft-vs-host disease
E Sorenson, R McAndrew, V Patel, AC Logan… - JAMA …, 2015 - jamanetwork.com
Importance Chronic graft-vs-host disease (GVHD) affects 50% to 70% of patients who
receive allogeneic hematopoietic cell transplants (HCTs), and the skin is the most common …
receive allogeneic hematopoietic cell transplants (HCTs), and the skin is the most common …